Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 432


Risk of human papillomavirus-associated cancers among persons with AIDS.

Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.

J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30. doi: 10.1093/jnci/djp205. Epub 2009 Jul 31.


Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.

J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491. Epub 2013 Jan 7.


StatBite: Proportion of specific cancers caused by HPV.

[No authors listed]

J Natl Cancer Inst. 2010 Jun 16;102(12):839. doi: 10.1093/jnci/djq224. Epub 2010 Jun 8. No abstract available.


HPV-related cancers after solid organ transplantation in the United States.

Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA.

Am J Transplant. 2013 Dec;13(12):3202-9. doi: 10.1111/ajt.12472. Epub 2013 Oct 1.


Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.

Balamurugan A, Ahmed F, Saraiya M, Kosary C, Schwenn M, Cokkinides V, Flowers L, Pollack LA.

Cancer. 2008 Nov 15;113(10 Suppl):2919-25. doi: 10.1002/cncr.23746.


Spectrum of cancer risk late after AIDS onset in the United States.

Simard EP, Pfeiffer RM, Engels EA.

Arch Intern Med. 2010 Aug 9;170(15):1337-45. doi: 10.1001/archinternmed.2010.253.


Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort..

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.


Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.


Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS.

Cancer. 2013 Jun 15;119(12):2291-9. doi: 10.1002/cncr.27989. Epub 2013 Apr 11.


Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.


AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study..

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.


Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.


Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB.

Cancer. 2008 Nov 15;113(10 Suppl):2841-54. doi: 10.1002/cncr.23758.


Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S.

Frisch M, Goodman MT.

Cancer. 2000 Mar 15;88(6):1464-9.


Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.

Eur J Cancer. 2015 Sep;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001. Epub 2015 Jun 26.


Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.


US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup..

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086. Print 2015 Jun.


Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Strickler HD.

J Natl Cancer Inst. 2009 Aug 19;101(16):1103-5. doi: 10.1093/jnci/djp236. Epub 2009 Jul 31. No abstract available. Erratum in: J Natl Cancer Inst. 2009 Oct 7;101(19):1364.


Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.

Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK.

PLoS One. 2014 Feb 5;9(2):e88323. doi: 10.1371/journal.pone.0088323. eCollection 2014.

Supplemental Content

Support Center